Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06633445
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-10-01
Brief Title:
Injecting Lateral Pterygoid Muscle by Botulinum Toxin Type A With 2 Different Methods 3D Guided Appliance and Electromyography EMG
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of 3D Guided Botulinum Toxin Type A Injection in Lateral Pterygoid Muscle for Management of Patients With Anterior Disc Displacement With Reduction a Randomized Controlled Clinical Trial
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to evaluate intra-oral botulinum toxin type A injection into lateral pterygoid muscle using a surgical guide synthesized by virtual planning based on CT with soft tissue window
To evaluate improvement of maximum interincisal opening MIO before and after injection
To assess change in disc position before and after injection
To evaluate recovery of symptoms as clicking tenderness of TMJ and tenderness of lateral pterygoid muscle after injection
Researchers will compare intra-oral botulinum toxin type A injection using a surgical guide synthesized by virtual planning based on CT with soft tissue window to conventional EMG guided botulinum toxin injection into lateral pterygoid muscle in patient with anterior disc displacement with reduction
Participants will be injected with botulinum toxin type A by intraoral approach
To evaluate improvement of maximum interincisal opening MIO before and after injection
To assess change in disc position before and after injection
To evaluate recovery of symptoms as clicking tenderness of TMJ and tenderness of lateral pterygoid muscle after injection
Researchers will compare intra-oral botulinum toxin type A injection using a surgical guide synthesized by virtual planning based on CT with soft tissue window to conventional EMG guided botulinum toxin injection into lateral pterygoid muscle in patient with anterior disc displacement with reduction
Participants will be injected with botulinum toxin type A by intraoral approach
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None